Raykov Rosty bought FENC
September 5, 2025 · Form 4 insider transaction
Raykov Rosty bought 36,207 shares of Fennec Pharmaceuticals Inc. at $2.45 per share, a transaction worth $88.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
36,207
Price
$2.45
Total value
$88.7K
InsiderRaykov Rosty
RoleDirector
SecurityCommon shares
Transaction codeM: Option exercise
Transaction dateSeptember 5, 2025
Filing dateSeptember 8, 2025
Shares owned after87,293
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.